Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor

被引：0

作者：

G. N. Zyuz’kov

V. V. Zhdanov

E. V. Udut

L. A. Miroshnichenko

E. V. Simanina

T. Yu. Polyakova

L. A. Stavrova

V. V. Udut

M. Yu. Minakova

A. M. Dygai

机构：

[1] E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine,

[2] National Research Tomsk State University,undefined

来源：

Bulletin of Experimental Biology and Medicine | 2016年 / 162卷

关键词：

signal pathways; JAK; progenitor cells; regenerative medicine; fibroblast growth factor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We studied the involvement of individual JAK kinases in the realization of the growth potential of mesenchymal precursors under the effect of fibroblast growth factor. The important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells and participation of JAK1 in this process under conditions of cytokine stimulation of progenitor cells were demonstrated. Specific inhibitors of these kinases reduced the yield of fibroblast CFU and the rate of their division. Moreover, blockade of JAK1, JAK2, and JAK3 under the effect of fibroblast growth factor was accompanied by an increase in the intensity of progenitor cell differentiation.

引用

页码：240 / 243

页数：3

共 50 条

[31] Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation
Fridman, Jordan S.
Scherle, Peggy A.
Collins, Robert
Burn, Timothy
Neilan, Claire L.
Hertel, Denise
Contel, Nancy
Haley, Patrick
Thomas, Beth
Shi, Jack
Collier, Paul
Rodgers, James D.
Shepard, Stacey
Metcalf, Brian
Hollis, Gregory
Newton, Robert C.
Yeleswaram, Swamy
Friedman, Steven M.
Vaddi, Kris
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (09) : 1838 - 1844
[32] Atomic Simulation of the Binding of JAK1 and JAK2 with the Selective Inhibitor Ruxolitinib
Kondratyev, Maxim
Rudnev, Vladimir R.
Nikolsky, Kirill S.
Stepanov, Alexander A.
Petrovsky, Denis, V
Kulikova, Liudmila, I
Kopylov, Arthur T.
Malsagova, Kristina A.
Kaysheva, Anna L.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
[33] Immunohistochemical analysis of the JAK family members in inflammatory skin diseases reveals increased expression of JAK1 and JAK3
de Medeiros, A. K. Alves
De Schepper, S.
Lambert, J.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S12 - S12
[34] Preclinical characterization of JAK1/JAK2 inhibitors for treatment of type 1 diabetes
Scott, N. A.
Trivedi, P. M.
Graham, K. L.
Fynch, S.
Jenkins, M. R.
Kay, T. W.
Thomas, H. E.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 361 - 361
[35] RANTES activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells
Wong, M
Uddin, S
Majchrzak, B
Huynh, T
Proudfoot, AEI
Platanias, LC
Fish, EN
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 11427 - 11431
[36] Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia
D Bellanger
V Jacquemin
M Chopin
G Pierron
O A Bernard
J Ghysdael
M-H Stern
Leukemia, 2014, 28 : 417 - 419
[37] Inhibitors of JAK2 and JAK3: an update on the patent literature 2010-2012
Dymock, Brian W.
See, Cheng Shang
EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (04) : 449 - 501
[38] INTERACTION OF JAK3 AND JAK1 TYROSINE KINASES WITH THE IL4 RECEPTOR COMPLEX
MALABARBA, MG
KIRKEN, RA
RUI, H
KAWAMURA, M
OSHEA, JJ
FARRAR, WL
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 55 - 55
[39] The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH
Smit, LS
Meyer, DJ
Billestrup, N
Norstedt, G
Schwartz, J
CarterSu, C
MOLECULAR ENDOCRINOLOGY, 1996, 10 (05) : 519 - 533
[40] Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia
Bellanger, D.
Jacquemin, V.
Chopin, M.
Pierron, G.
Bernard, O. A.
Ghysdael, J.
Stern, M-H
LEUKEMIA, 2014, 28 (02) : 417 - 419

← 1 2 3 4 5 →